NOV Inc (NOV) concluded trading on Thursday at a closing price of $15.10, with 4.72 million shares of worth about $71.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.87% during that period and on March 20, 2025 the price saw a gain of about 0.53%. Currently the company’s common shares owned by public are about 381.55M shares, out of which, 377.24M shares are available for trading.
Stock saw a price change of 7.93% in past 5 days and over the past one month there was a price change of -1.18%. Year-to-date (YTD), NOV shares are showing a performance of 3.42% which decreased to -18.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.77 but also hit the highest price of $21.20 during that period. The average intraday trading volume for NOV Inc shares is 4.51 million. The stock is currently trading 3.18% above its 20-day simple moving average (SMA20), while that difference is up 1.02% for SMA50 and it goes to -7.65% lower than SMA200.
NOV Inc (NYSE: NOV) currently have 381.55M outstanding shares and institutions hold larger chunk of about 101.99% of that.
The stock has a current market capitalization of $5.75B and its 3Y-monthly beta is at 1.38. PE ratio of stock for trailing 12 months is 9.39, while it has posted earnings per share of $1.61 in the same period. Its PEG reads 0.74 and has Quick Ratio of 1.64 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NOV, volatility over the week remained 2.60% while standing at 3.17% over the month.
Stock’s fiscal year EPS is expected to rise by 11.58% while it is estimated to increase by 19.59% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Evercore ISI on January 15, 2025 offering an In-line rating for the stock and assigned a target price range of between $25 and $18 to it. On December 19, 2024, Piper Sandler Initiated their recommendations, while on November 11, 2024, Citigroup Downgrade their ratings for the stock with a price target of $18. Stock get a Buy rating from TD Cowen on October 28, 2024.
